Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant have?
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant has 878 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant published?
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant has 2000 year in the ScholarIQ index.
What is the open-access status of Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant?
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant has bronze oa status in the ScholarIQ index.
What is the DOI of Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant?
The DOI for Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant is on the source record.
What is the PMID of Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant?
The PMID for Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant is on the source record.
What is the OpenAlex record for Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant?
The OpenAlex for Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant is on the source record.